Cannabis stocks buzzing on social media post from President Trump

Cannabis Industry & Policy - President Trump shared a video highlighting the health benefits of hemp-derived CBD, potentially revolutionizing senior healthcare as an alternative to costly prescription drugs [1][2] - The 2018 Farm Bill legalized hemp-derived products like CBD [3] - Trump hinted at reclassifying cannabis from a Schedule 1 drug to a less dangerous Schedule 3, alongside steroids and Tylenol with codeine [3] - Reclassification would ease criminal penalties, lift tax burdens on companies, and open the pathway to more medical research [4] - New HHS standards for "accepted medical use" acknowledge widespread physician use and some credible scientific support, rather than demanding full FDA level clinical trial evidence [4] Market Reaction & Stock Performance - Tilray, Canopy Growth, and Aurora are all jumping double digits [2] - The cannabis sector has been volatile, with some stocks halving in value this year and others gaining over 30% [5] - Investors are reacting positively to the news regarding potential reclassification [5] Regulatory Process & Future Outlook - The decision to reclassify cannabis needs to come from the administration [6] - The previous administration did a lot of the work in terms of reclassification, putting forward the DEA's recommendation and opening it for public comment [6] - The current administration has the power to expedite the reclassification process [6] - Rescheduling could move cannabis stocks forward [7]